학술논문
Empagliflozin to prevent progressive adverse remodelling after myocardial infarction (EMPRESS-MI): rationale and design
Document Type
Article
Author
Source
In: ESC Heart Failure . (ESC Heart Failure, August 2024, 11(4):2001-2012)
Subject
Language
English
ISSN
20555822